<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lin</surname>
    <given-names>JT</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>JS</given-names>
   </name>
   <name>
    <surname>Su</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>JG</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>JT</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>YX</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>YP</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine</article-title>
  <source>Antivir Ther (Lond)</source>
  <year>2007</year>
  <volume>12</volume>
  <fpage>1107</fpage>
  <lpage>1113</lpage>
  <pub-id pub-id-type="pmid">18018769</pub-id>
 </element-citation>
</ref>
